EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cancer Therapy-related Cardiotoxicity is Associated with Distinct Alterations of the Myocardial Lipidome

Vera M Braun iD, Anna Foryst-Ludwig, Ulf Landmesser iD, István Baczkó iD, Hendrik Milting iD, Ulrich Kintscher iD, Niklas Beyhoff iD

European Journal of Heart Failure · 01.06.2025 · 27 (6) · 1056-1066

DOI: 10.1002/ejhf.3656 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Heart Failure, online erschienen am 01.05.2025. Verfasst von Vera M Braun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacology, Max Rubner Center for Cardiovascular Metabolic Renal Research, Charité - Universitätsmedizin Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Cardiotoxicity, Myocardium, Lipid Metabolism, Anthracyclines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsches Zentrum für Herz-Kreislaufforschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Anthracyclines are key components of various chemotherapy regimens, but their clinical utility is limited by severe cardiotoxic side effects. Previous studies have suggested that anthracycline-induced cardiotoxicity (AIC) may be driven by alterations in myocardial lipid metabolism. This study aimed to systematically explore the cardiac lipidomic landscape of AIC with regard to potential pathomechanisms and novel therapeutic targets. Methods and results Mass spectrometry-based untargeted lipidomics were performed on myocardial biopsies from 13 patients with AIC (age 53 ± 31 years, 54% female, left ventricular ejection fraction 19 ± 4%) and 15 age- and sex-matched controls. Lipidomic profiles were also compared with 15 patients with other heart failure aetiologies (matched for sex and age). A total of 627 individual lipid species from 22 different lipid classes were analysed. AIC was associated with a lower proportion of polyunsaturated fatty acids towards more monounsaturated and saturated sidechains as well as significant alterations in the proportion of odd-chain fatty acids. Pathway analyses indicated a higher precursor conversion into lysolipids in AIC. This accumulation of lysolipid species was not observed in other heart failure aetiologies and may represent a specific finding in AIC.

Conclusion

Anthracycline-induced cardiotoxicity leads to distinct alterations of the myocardial lipidome. Increased levels of myocardial lysolipids were identified as a novel lipidomic trait in AIC, which appears to be distinct from other causes of heart failure. Further research studying pharmacological interventions in lysolipid metabolism for prevention and therapy of AIC is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiotoxicityMyocardiumLipid MetabolismAnthracyclinesNeoplasmsHeart FailureHumansFemaleMiddle AgedMaleLipidomicsStroke VolumeAdultBiopsyAgedVentricular Function, Left

Stichwörter der Autor:innen

AnthracyclinesCancer therapy‐related cardiac dysfunctionCardiomyopathyCardiotoxicityLipidomicsLipids

Substanzen

Anthracyclines

Autor:innen und Institutionen

  • Institute of Pharmacology, Max Rubner Center for Cardiovascular Metabolic Renal Research, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.
  • Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité, Berlin, Germany.
  • Department of Pharmacology and Pharmacotherapy, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
  • Erich and Hanna Klessmann Institute for Cardiovascular Research and Development, Clinic for Thoracic and Cardiovascular Surgery, Heart and Diabetes Center NRW, Bad Oeynhausen, Germany.

ORCID-Profile: Vera M Braun, Ulf Landmesser, István Baczkó, Hendrik Milting, Ulrich Kintscher, Niklas Beyhoff

Förderung

  • Deutsches Zentrum für Herz-Kreislaufforschung

Zitieren

APA

Braun, V. M., Foryst-Ludwig, A., Landmesser, U., Baczkó, I., Milting, H., Kintscher, U., & Beyhoff, N. (2025). Cancer Therapy-related Cardiotoxicity is Associated with Distinct Alterations of the Myocardial Lipidome. European Journal of Heart Failure, 27(6), 1056-1066. https://doi.org/10.1002/ejhf.3656

Vancouver

Braun VM, Foryst-Ludwig A, Landmesser U, Baczkó I, Milting H, Kintscher U, et al. Cancer Therapy-related Cardiotoxicity is Associated with Distinct Alterations of the Myocardial Lipidome. European Journal of Heart Failure. 2025;27(6):1056-1066. doi:10.1002/ejhf.3656

BibTeX
@article{Braun2025,
  author = {Braun, Vera M and Foryst-Ludwig, Anna and Landmesser, Ulf and Baczkó, István and Milting, Hendrik and Kintscher, Ulrich and Beyhoff, Niklas},
  title = {Cancer Therapy-related Cardiotoxicity is Associated with Distinct Alterations of the Myocardial Lipidome},
  journal = {European Journal of Heart Failure},
  year = {2025},
  volume = {27},
  number = {6},
  pages = {1056--1066},
  doi = {10.1002/ejhf.3656}
}
Kostenlos starten →